(Q3)Nov 30, 2021 | (Q2)Aug 31, 2021 | (Q1)May 31, 2021 | (FY)Feb 28, 2021 | (Q4)Feb 28, 2021 | (Q3)Nov 30, 2020 | (Q2)Aug 31, 2020 | (Q1)May 31, 2020 | (FY)Feb 29, 2020 | (Q4)Feb 29, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 16.03%16.01K | 154.88%16.19K | -3,057.72%-30.47K | -420.93%-83.19K | -734.63%-66.52K | 254.04%13.8K | -321.72%-29.51K | -112.13%-965 | 93.05%-15.97K | -109.53%-7.97K |
Net income from continuing operations | 118.09%10.19K | -114.36%-1.4K | 30.18%-22.53K | 73.86%-175.04K | 83.56%-96.19K | -121.22%-56.32K | 131.88%9.74K | -12.83%-32.27K | -110.95%-669.59K | -1,249.61%-584.99K |
Asset impairment expenditure | ---- | ---- | ---- | -97.54%13.17K | ---- | ---- | ---- | ---- | --534.44K | ---- |
Change In working capital | -91.70%5.82K | 144.82%17.59K | -125.37%-7.94K | -33.98%78.68K | -61.24%16.5K | 324.97%70.12K | -266.69%-39.25K | -14.37%31.3K | 426.89%119.17K | -66.46%42.58K |
-Change in receivables | ---- | ---- | -2.49%-699 | -444.33%-6.19K | -281.70%-3.67K | -174.62%-1.82K | 96.32%-17 | -171.87%-682 | -143.55%-1.14K | -122.82%-962 |
-Change in prepaid assets | ---- | ---- | ---5K | ---- | ---- | ---- | -542.09%-5K | --0 | 161.59%3.37K | -81.24%1.01K |
-Change in payables and accrued expense | -91.30%5.82K | 134.74%11.89K | -107.01%-2.24K | -27.43%84.87K | -52.56%20.17K | 290.04%66.94K | -249.63%-34.23K | -6.97%31.99K | 448.04%116.94K | -63.76%42.52K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 16.04%16.01K | 154.88%16.19K | -3,057.72%-30.47K | -420.93%-83.19K | -734.63%-66.52K | 254.02%13.8K | -321.71%-29.51K | -112.13%-965 | 93.05%-15.97K | -109.53%-7.97K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 98.50%-3.1K | 0 | ||||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.50%-3.1K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.50%-3.1K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -703.38%-37.84K | 1,055.48%167.54K | 1,794.16%151.53K | 53.86K | -44.12K | -3.51%6.27K | -96.71%14.5K | 8K | ||
Net common stock issuance | ---- | ---- | ---- | --145K | ---- | ---- | ---- | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | -703.38%-37.84K | 55.48%22.54K | -18.34%6.53K | --53.86K | ---44.12K | -3.51%6.27K | 1,712.50%14.5K | --8K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | 185.78%37.84K | -703.38%-37.84K | 1,055.48%167.54K | 1,794.16%151.53K | --53.86K | ---44.12K | -3.51%6.27K | -96.71%14.5K | --8K |
Net cash flow | ||||||||||
Beginning cash position | -27.03%12.64K | 162.69%17.32K | 6,554.08%85.64K | -78.03%1.29K | -50.28%625 | 688.08%17.32K | -28.29%6.59K | -78.03%1.29K | 503.81%5.86K | -97.34%1.26K |
Current changes in cash | -76.33%16.01K | 173.40%54.04K | -1,387.28%-68.32K | 1,945.75%84.35K | 283,276.67%85.01K | 7,289.59%67.65K | -952.21%-73.62K | 58.99%5.31K | -193.51%-4.57K | 100.07%30 |
End cash Position | 2,199.84%14.37K | -27.03%12.64K | 162.69%17.32K | 6,554.08%85.64K | 6,554.08%85.64K | -50.28%625 | 688.08%17.32K | -28.29%6.59K | -78.03%1.29K | -78.03%1.29K |
Free cash from | 16.04%16.01K | 154.88%16.19K | -3,057.72%-30.47K | -336.25%-83.19K | -734.63%-66.52K | 1,566.42%13.8K | -321.71%-29.51K | 69.48%-965 | 95.63%-19.07K | 80.76%-7.97K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.